Search Results
Jun 01, 2026, 07:51 ET CHR Group Acquires Rmoni and Andy to Help Establish itself as a Leading Digital Partner for the Foodservice Industry
foodservice operators.Together with CHR's flagship platforms, ePackPro and Adoria, the acquisitions significantly strengthen CHR's international footprint and broaden
More news about: CHR Group
Jun 01, 2026, 07:39 ET CHR Group Acquires Rmoni and Andy to Help Establish itself as a Leading Digital Partner for the Foodservice Industry
foodservice operators.Together with CHR's flagship platforms, ePackPro and Adoria, the acquisitions significantly strengthen CHR's international footprint and broaden
More news about: CHR Group
May 14, 2026, 09:00 ET Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
Inc. (NASDAQ: ARTV), Fate Therapeutics, Inc. (NASDAQ: FATE), ImmunityBio, Inc. (NASDAQ: IBRX), Coherus Oncology, Inc. (NASDAQ: CHRS).
More news about: Market News Updates
Jan 27, 2026, 10:50 ET Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
(NASDAQ: ONCY), Moderna (NASDAQ: MRNA), Merck (NYSE: MRK), Vir Biotechnology (NASDAQ: VIR), and Coherus Oncology (NASDAQ: CHRS) at the intersection of pivotal execution readiness and combination immunotherapy innovation in high-unmet-need gastrointestinal and respiratory cancer
More news about: Equity Insider
Jan 16, 2026, 08:00 ET Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
ImmunityBio (NASDAQ: IBRX), Erasca, Inc. (NASDAQ: ERAS), NovaBridge Biosciences (NASDQ: NBP), and Coherus Oncology (NASDAQ: CHRS).
More news about: Equity Insider